简介：Researchers from Korea are studying the relationship between serum levels of vascular endothelial growth factors (VEGF) and treatment response to a combination sorafenib and transarterial chemoembolization (TACE) therapy. “VEGF overexpression，” writes Dr. Lee， “was a significant predictor of a favorable clinical outcome.”